Intractable & Rare Diseases Research

Scope & Guideline

Pioneering Research in Rare Disease Solutions.

Introduction

Delve into the academic richness of Intractable & Rare Diseases Research with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2186-3644
PublisherINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
Support Open AccessNo
CountryJapan
TypeJournal
Convergefrom 2012 to 2024
AbbreviationINTRACTABLE RARE DIS / INTRACTABLE RARE DIS. RES.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT, TOKYO 00000, JAPAN

Aims and Scopes

The journal 'Intractable & Rare Diseases Research' focuses on the complex landscape of rare and intractable diseases, providing a platform for innovative research that addresses both clinical and scientific challenges. Its aim is to enhance understanding, diagnosis, and treatment of these conditions through rigorous analysis and interdisciplinary collaboration.
  1. Epidemiology of Rare Diseases:
    The journal emphasizes the importance of understanding the prevalence and distribution of rare diseases, including comprehensive epidemiological studies that highlight the burden these conditions place on healthcare systems.
  2. Genetic and Molecular Research:
    Research on the genetic underpinnings of rare diseases is a core focus, including studies on genetic mutations, biomarkers, and the development of genetic diagnostics that facilitate better patient management.
  3. Clinical Management and Treatment Approaches:
    Papers often explore novel treatment strategies and management protocols for rare diseases, including case studies, clinical trials, and reviews that contribute to improved patient outcomes.
  4. Patient-Centered Research:
    The journal prioritizes research that includes patient perspectives, quality of life assessments, and psychosocial impacts of living with rare diseases, fostering a holistic understanding of these conditions.
  5. Innovative Technologies in Rare Disease Research:
    There is a consistent interest in the application of advanced technologies, such as artificial intelligence and metabolomics, to improve diagnostics, treatment efficacy, and understanding of disease mechanisms.
The journal has identified and embraced several emerging themes that reflect the evolving landscape of rare disease research. These trends highlight areas of growing importance and potential impact on clinical practice and patient care.
  1. Integration of Artificial Intelligence in Rare Disease Research:
    A significant trend is the increasing incorporation of artificial intelligence technologies in diagnosing and managing rare diseases, showcasing innovative methodologies that enhance precision medicine.
  2. Focus on Quality of Life and Patient Experiences:
    There is a growing emphasis on understanding the quality of life and psychological impacts of rare diseases, indicating a shift towards more holistic patient-centered research.
  3. Innovations in Genetic Diagnostics:
    Emerging themes include advances in genetic diagnostics, such as whole-exome sequencing and next-generation sequencing technologies, which are revolutionizing the understanding and management of genetic disorders.
  4. Interdisciplinary Collaborations:
    Research that involves interdisciplinary approaches, combining insights from genetics, epidemiology, and clinical practice, is increasingly prominent, reflecting the complex nature of rare diseases.
  5. Emerging Treatments and Therapeutics:
    There is a rising interest in novel therapeutic approaches, including gene therapies and personalized medicine strategies, that promise to address unmet needs in rare disease treatment.

Declining or Waning

While the journal has seen a rich variety of themes over the years, certain areas appear to be declining in prominence. This may reflect shifts in research focus or advancements in knowledge and technology that have rendered some topics less critical.
  1. General Reviews of Rare Diseases:
    There has been a noticeable decrease in broader reviews of rare diseases as more targeted, specific studies emerge. The focus is shifting towards in-depth analyses rather than general overviews.
  2. Historical Perspectives:
    Papers that provide historical context or retrospective analyses of rare diseases are appearing less frequently, suggesting a trend towards more forward-looking research that emphasizes current issues and future directions.
  3. Basic Science without Clinical Relevance:
    Research that delves into basic science aspects of rare diseases without a clear clinical application or relevance is becoming less common, as the journal increasingly favors studies that bridge the gap between laboratory findings and clinical practice.
  4. Epidemiological Studies in Developed Regions:
    There appears to be a waning interest in epidemiological studies focused solely on developed countries, likely as the journal aims to highlight the global burden of rare diseases, particularly in under-researched regions.

Similar Journals

KEIO JOURNAL OF MEDICINE

Innovating Healthcare Through Rigorous Research
Publisher: KEIO JOURNAL MEDICINEISSN: 0022-9717Frequency: 4 issues/year

KEIO JOURNAL OF MEDICINE, published by the Keio University in Japan, is an esteemed medical journal that has been a cornerstone of medical research since its inception in 1952. With an ISSN of 0022-9717 and an E-ISSN of 1880-1293, this journal plays a crucial role in disseminating valuable research across various disciplines within the field of medicine. Currently ranking in the Q3 quartile in the category of Medicine (miscellaneous) and holding a commendable Scopus Ranks of #168 out of 636 publishers, it stands in the 73rd percentile, highlighting its growing impact in the academic community. The journal's commitment to enhancing medical knowledge is evident through its rigorous peer-review process, aiming to provide high-quality content that appeals to researchers, practitioners, and students alike. Although the journal operates under a subscription model, it remains a vital resource for those invested in advancing the field of medicine, addressing contemporary challenges, and exploring innovations in medical practice.

SAGE Open Medical Case Reports

Connecting Professionals with Pioneering Medical Cases
Publisher: SAGE PUBLICATIONS INCISSN: 2050-313XFrequency: 1 issue/year

SAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.

ORVOSI HETILAP

Your Gateway to Essential Medical Research
Publisher: AKADEMIAI KIADO ZRTISSN: 0030-6002Frequency: 52 issues/year

ORVOSI HETILAP is a pivotal journal in the field of general medicine, published by AKADEMIAI KIADO ZRT in Hungary. With its rich history dating back to 1949, this journal has been a platform for disseminating significant research findings and clinical advancements that impact healthcare practices. Although it currently falls within the Q4 category in the 2023 ranking of Medicine (miscellaneous), it holds a Scopus rank of #320 among 636 journals in its category, indicating its growing recognition among peers and scholars. The journal does not offer open access options, which may limit broader dissemination, but it nonetheless remains an important resource for medical professionals, researchers, and students engaging with contemporary medical issues. Located in the vibrant academic landscape of Budapest, ORVOSI HETILAP continues to contribute to the evolving dialogue in the medical community, showcasing diverse topics and fostering interdisciplinary collaboration.

Cold Spring Harbor Molecular Case Studies

Bridging the gap between molecular research and patient care.
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2373-2873Frequency: 6 issues/year

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.

Orphanet Journal of Rare Diseases

Advancing knowledge in rare diseases.
Publisher: BMCISSN: Frequency: 1 issue/year

The Orphanet Journal of Rare Diseases, published by BMC since 2006, serves as a vital platform for the dissemination of groundbreaking research in the realm of rare diseases. With a notable Q1 ranking in both the Medicine (miscellaneous) and Pharmacology (medical) categories, and a respectable Q2 ranking in Genetics (clinical), the journal is recognized for its impactful contributions, evidenced by its position in the top quartiles of Scopus rankings. This open-access journal allows unrestricted access to its content, promoting a global exchange of knowledge among researchers, healthcare professionals, and academics. By covering a broad spectrum of rare diseases, the Orphanet Journal aims to enhance awareness, improve diagnosis and treatment, and ultimately contribute to the improvement of patients' lives. With a commitment to high-quality research, this journal stands as an essential resource for anyone involved in the study or treatment of rare diseases.

Journal of Pediatric Infectious Diseases

Illuminating the path to improved child health outcomes.
Publisher: GEORG THIEME VERLAG KGISSN: 1305-7707Frequency: 4 issues/year

Journal of Pediatric Infectious Diseases, published by GEORG THIEME VERLAG KG, serves as a vital platform for the dissemination of cutting-edge research in the fields of pediatric infectious diseases and related areas. With an ISSN of 1305-7707 and an E-ISSN of 1305-7693, this journal endeavors to address critical issues and innovations in pediatric medicine, fostering an understanding of infectious diseases that affect children. The journal is indexed in Scopus, where it holds a Q4 ranking in both Infectious Diseases and Pediatrics, Perinatology and Child Health, reflecting its emerging status within medical research. Although currently not open access, it offers valuable insights and empirical research crucial for healthcare professionals, researchers, and students dedicated to improving pediatric care. The Journal of Pediatric Infectious Diseases not only highlights contemporary challenges faced by pediatric health practitioners but also aims to be a cornerstone for future developments in the management and prevention of infections in young populations.

YONAGO ACTA MEDICA

Advancing Medical Knowledge Since 1965
Publisher: TOTTORI UNIV MEDICAL PRESSISSN: 0513-5710Frequency: 4 issues/year

YONAGO ACTA MEDICA, published by Tottori University Medical Press, is a prominent journal in the field of Medicine, recognized for its contributions and academic rigor since its inception in 1965. With an ISSN of 0513-5710 and E-ISSN of 1346-8049, this journal is situated in Japan and spans significant periods of convergence from 1965 to 1977 and from 1986 to 2024. Classified within the Q3 category of Medicine (Miscellaneous) and holding a respectable Scopus rank of 275 out of 636 in General Medicine, YONAGO ACTA MEDICA offers an invaluable platform for researchers, professionals, and students to disseminate innovative studies and findings in diverse medical topics. While the journal currently does not operate under an open-access model, it remains committed to promoting academic excellence and advancing medical knowledge through peer-reviewed publications. Address inquiries and contributions to 86 NISHI-CHO, YONAGO, TOTTORI-KEN 683-8503, JAPAN.

Case Reports in Immunology

Exploring the Frontiers of Immunological Case Studies
Publisher: HINDAWI LTDISSN: 2090-6609Frequency:

Case Reports in Immunology, published by HINDAWI LTD, is an esteemed open-access journal that has been contributing to the field of immunology since its launch in 2011. With both ISSN 2090-6609 and E-ISSN 2090-6617, the journal provides a platform for researchers to publish detailed case reports that explore diverse immunological conditions and novel treatment approaches. This journal is crucial for clinicians, researchers, and students alike, seeking to broaden their understanding of immunology's practical applications and advances. As of 2023, it holds a Q3 ranking in Immunology and Q2 in Immunology and Allergy, reflecting its growing relevance and contribution to the field. Additionally, it is indexed in Scopus, where it ranks #178 in Immunology and Allergy and #192 in Immunology and Microbiology, enhancing its visibility and impact. With a comprehensive accessibility model, the journal is dedicated to disseminating knowledge widely and enriching discussions in immunological research.

IDCases

Empowering healthcare through shared knowledge.
Publisher: ELSEVIER SCI LTDISSN: 2214-2509Frequency: 1 issue/year

Welcome to IDCases, a peer-reviewed open access journal published by Elsevier Science Ltd that has been at the forefront of infectious disease research since 2014. With a ISSN of 2214-2509, IDCases is dedicated to the publication of high-quality case reports and novel findings in the field of infectious diseases, aiming to enhance clinical practice and guide therapeutic decision-making. Positioned in the Q3 Quartile of the infectious diseases category, and ranked #213 out of 344 in Scopus’s Medicine _ Infectious Diseases category, the journal establishes essential connections between academia and the healthcare community. As an open access journal, IDCases ensures that critical research is disseminated widely, fostering collaboration and innovation in managing infectious diseases. By encouraging submissions that explore both common and rare infections, global outbreaks, and novel therapeutic approaches, IDCases serves as a critical resource for researchers, healthcare professionals, and students alike. Join us in advancing the discourse and understanding of infectious diseases!

Case Reports in Oncological Medicine

Empowering healthcare professionals with valuable case reports.
Publisher: HINDAWI LTDISSN: 2090-6706Frequency: 1 issue/year

Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.